Rat model of chronic lung infections caused by nontypable Haemophilus influenzae

References

1. Reynolds HY. Chronic bronchitis and acute infectious exacerbations. Mandell GL, Douglas RG, Bennett JE. eds Principles and practice of infectious diseases, 2nd. New York: John Wiley and Sons; 1985387–390
   [Google Scholar]
2. Pressler T, Szaff M, Hoiby N. Antibiotic treatment of Haemophilus influenzae and Haemophilus parainfluenzae infections in patients with cystic fibrosis. Acta Paediatr Scand 1984; 73:541–547
   [Google Scholar]
3. Pedersen M, Stevring S, Merkassel E, Koch C, Heiby N. A comparative study of amoxycillin and pivampicillin in persistent Heamophilus influenzae infection of the lower respiratory tract in children with chronic lung disease. Scand J Infec Dis 1986; 18:245–254
   [Google Scholar]
4. Tager I, Speizer FE. Role of infection in chronic bronchitis. N Engl J Med 1975; 292:563–571
   [Google Scholar]
5. Murphy TF, Apicella MA. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev Infect Dis 1987; 9:1–15
   [Google Scholar]
6. Cole P. A new look at the pathogenesis and management of persistent bronchial sepsis. Davies RJ. ed Strategies for the management of chronic bronchial sepsis Oxford: Medicine Publishing Foundation; Symposium Series 12 19841–20
   [Google Scholar]
7. Marks MI. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr 1981; 98:173–179
   [Google Scholar]
8. Denny FW. Effect of a toxin produced by Haemophilus influenzae on ciliated respiratory epithelium. J Infect Dis 1974; 129:93–100
   [Google Scholar]
9. Johnson AP, Inzana TJ. Loss of ciliary activity in organ cultures of rat trachea treated with lipo-oligosaccharide from Haemophilus influenzae. J Med Microbiol 1986; 22:265–268
   [Google Scholar]
10. Sheinman BD, Devalia JL, Davies RJ, Crook SJ, Tabaqchali S. Synthesis of histamine by Haemophilus influenzae. Br Med J 1986; 292:857–858
    [Google Scholar]
11. Devalia JL, Grady D, Harmanyeri Y, Tabaqchali S, Davies RJ. Histamine synthesis by respiratory tract microorganisms: possible role in pathogenicity. J Clin Pathol 1989; 42:516–522
    [Google Scholar]
12. Cash HA, Woods DE, McCullough B, Johanson WG, Bass JA. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis 1979; 119:453–459
    [Google Scholar]
13. Cash HA, Straus DC, Bass JA. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors. Can J Microbiol 1983; 29:448–456
    [Google Scholar]
14. Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980; 28:546–556
    [Google Scholar]
15. Cochrane DMG, Brown MRW, Anwar H, Weller PH, Lam A, Costerton JW. Antibody response to Pseudomonas aeruginosa surface protein antigens in a rat model of chronic lung infection. J Med Microbiol 1988; 27:255–261
    [Google Scholar]
16. Nicas TI, Frank DW, Stenzel P, Lile JD, Iglewski BH. Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections. Eur J Clin Microbiol 1985; 4:175–179
    [Google Scholar]
17. Woods DE, Cryz SL, Friedman RL, Iglewski BH. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun 1982; 36:1223–1228
    [Google Scholar]
18. Woods DE, Bryan LE. Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. J Infect Dis 1985; 151:581–588
    [Google Scholar]
19. Slater LN. A rat model of prolonged non-lethal pulmonary infection due to nontypeable (unencapsulated) Haemophilus influenzae. 86th Annual Meeting of the American Society for Microbiology 1986 Abstract B-195
    [Google Scholar]
20. Slater LN, Van Meter D, Emmons S. Effects of modification of host defences upon the duration of infection in a rat model of persistent pneumonia due to nontypable (unencapsulated) Haemophilus influenzae. 87th Annual Meeting of the American Society for Microbiology 1987 Abstract B-87
    [Google Scholar]
21. Lowry OH, Rosebrough N J, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265–275
    [Google Scholar]
22. Galanos C, Lüderitz O, Westphal O. A new method for the extraction of R lipopolysaccharide. Eur J Biochem 1969; 9:245–249
    [Google Scholar]
23. Niven DF, Donga J, Archibald FS. Responses of Haemophilus pleuropneumoniae to iron restriction: changes in the outer membrane protein profile and the removal of iron from porcine transferrin. Mol Microbiol 1989; 3:1083–1089
    [Google Scholar]
24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350–4354
    [Google Scholar]
25. Woods DE, Franklin R, Cryz S J, Ganss M, Peppier M, Ewanowich C. Development of a rat model for respiratory infection with Bordetella pertussis. Infect Immun 1989; 57:1018–1024
    [Google Scholar]
26. Jensen T, Pedersen SS, Stafanger G, Haiby N, Koch C, Bondesson G. Comparison of amoxycillin/clavulanate with amoxycillin in children and adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae. Scand J Infect Dis 1988; 20:517–524
    [Google Scholar]
27. Inzana TJ. Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae. J Infect Dis 1983; 148:492–499
    [Google Scholar]
28. Apicella MA, Dudas KC, Campagnari A, Rice P, Mylotte JM, Murphy TF. Antigenic heterogeneity of lipid A of Haemophilus influenzae. Infect Immun 1985; 50:9–14
    [Google Scholar]
29. Flesher AR, Insel RA. Characterization of the lipopolysaccharide of Haemophilus influenzae. J Infect Dis 1978; 138:719–730
    [Google Scholar]
30. Brogden KA, Cutlip RC, Lehmkuhl HD. Complexing of bacterial lipopolysaccharide with lung surfactant. Infect Immun 1986; 52:644–649
    [Google Scholar]
31. Hansen E J, Hart DA, McGehee JL, Toews GB. Immune enhancement of pulmonary clearance of nontypable Haemophilus influenzae. Infect Immun 1988; 56:182–190
    [Google Scholar]
32. Burns MW, May JR. Bacterial precipitins in serum of patients with cystic fibrosis. Lancet 1968; 1:270–272
    [Google Scholar]
33. Spinola SM, Peacock J, Denny FW, Smith DL, Cannon JG. Epidemiology of colonization by nontypable Haemophilus influenzae in children: a longitudinal study. J Infect Dis 1986; 154:100–109
    [Google Scholar]
34. Maciver I, Hill SH, O’Reilly T, Burnett D, Stockley RA, Brown MRW. Immune response of patients with bronchiectasis to outer membrane antigens of non-typable Haemophilus influenzae. Thorax 1988; 43:861P
    [Google Scholar]
35. Hansen MV, Musher DM, Baughn RE. Outer membrane proteins of nontypable Haemophilus influenzae and reactivity of paired sera from infected patients with their homologous isolates. Infect Immun 1985; 47:843–846
    [Google Scholar]
36. Clarke CW. In vivo and in vitro reactions to antigens of Haemophilus influenzae in bronchial obstruction. Br J Dis Chest 1979; 73:373–381
    [Google Scholar]
37. Harada T, Sakakura Y. Immunologic responses against lipopolysaccharide of Hemophilus influenzae in patients with acute sinusitis. Ann Otol Rhinol Laryngol 1988; 97:207–210
    [Google Scholar]
38. Groeneveld K, Eijk PP, Van Alphen L, Jansen HM, Zanen HC. Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum. Am Rev Respir Dis 1990; 141:1316–1321
    [Google Scholar]
39. Gump DW, Christmas WA, Forsyth BR, Phillips CA, Stouch WH. Serum and secretory antibodies in patients with chronic bronchitis. Arch Intern Med 1973; 132:847–851
    [Google Scholar]
40. Stockley RA, Burnett D. Alpha₁-antichymotrypsin in infected and noninfected sputum. Am Rev Respir Dis 1980; 122:81–88
    [Google Scholar]
41. McGehee JL, Radolf JD, Toews GB, Hansen EJ. Effect of primary immunization on pulmonary clearance of nontypable Haemophilus influenzae. Am J Resp Cell Mol Biol 1989; 1:201–210
    [Google Scholar]
42. Reynolds HY, Thompson RE. Pulmonary host defenses. 1. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with Pseudomonas aeruginosa. J Immunol 1973; 111:358–368
    [Google Scholar]
43. Reynolds HY, Newball HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974; 84:559–573
    [Google Scholar]
44. Musher DM, Goree A, Baughn RE, Birdsall HH. Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae. Infect Immun 1984; 45:36–40
    [Google Scholar]
45. Inzana TJ, Anderson P. Serum factor-dependent resistance of Haemophilus influenzae type b to antibody to lipopolysaccharide. J Infect Dis 1985; 151:869–877
    [Google Scholar]
46. Clancy R, Cripps A, Muree-Allen K, Yeung S, Engel M. Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet 1985; 2:1395–1397
    [Google Scholar]
47. Clancy RL, Cripps AW, Gebski V. Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae. Med J Aust 1990; 152:413–416
    [Google Scholar]
48. Hill SL, Morrison HM, Burnett D, Stockley RA. Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Thorax 1986; 41:559–565
    [Google Scholar]
49. Cole PJ, Roberts DE, Davies SF, Knight RK. A simple oral antimicrobial regimen effective in severe chronic bronchial suppuration associated with culturable Haemophilus influenzae. JAntimicrob Chemother 1983; 11:109–113
    [Google Scholar]
50. Maesen FPV, Davies BI, Baur C. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis. J Antimicrob Chemother 1987; 19:373–383
    [Google Scholar]